BIG: How much financing headroom really opened after the February 2026 bond raise
BIG's Series 25 bond raise in February 2026 opened real financing room, but not as much as a NIS 1 billion headline suggests. The covenants are wide; the real test is still liquidity, refinancing discipline, and how much more collateral the parent needs to mobilize.
The main article already argued that BIG's 2025 step-up was real, but that 2026 would be judged mainly through financing and project delivery. This continuation isolates only the financing question, because that is where the largest gap opens between how the headline sounds and what the year-end note plus the February 2026 financing documents actually say.
The short conclusion is straightforward: the February 2026 Series 25 issue opened real financing room, but mostly as refinancing room and duration extension, not as a full solution to the parent company's funding pressure. The covenants themselves are not tight. The practical bottleneck is still liquidity quality, collateral depth, and the need to keep commercial paper fully backstopped even after the raise.
- The raise refinances more than it liberates. The proceeds are earmarked, among other things, for the remaining Series H balance and for ongoing activity, and the BIG Fashion Ashdod collateral effectively moved from Series H to Series 25.
- Covenant room is very wide. The new series relies on equity and equity-to-balance-sheet tests, but those sit far below the actual year-end balance-sheet levels.
- The practical room sits outside the formula. It depends on an AFI-share-backed credit line, unpledged properties, the market value of AFI shares, and continued commercial-paper discipline.
What Actually Opened In February 2026
On January 26, 2026 the company first published a notice that it was examining a new secured series, Series 25, backed by collateral linked to BIG Ashdod. On the same day S&P Maalot assigned an ilAA rating for up to NIS 750 million par value, under a collateral framework tied to an 80% loan-to-value cap in the draft deed of trust. On February 8 that rating scope was expanded to up to NIS 1 billion par value, and on February 9 the company indeed issued NIS 1 billion par value of Series 25, with a fixed annual coupon of 2.37% and a single principal repayment on November 20, 2032.
The key point is not only that BIG raised NIS 1 billion. It is how it raised it. This was not generic balance-sheet borrowing. The security package sat on BIG Fashion Ashdod, insurance proceeds, shareholder loans into Shaar Ashdod Rail, and the company's indirect 72% stake in Shaar Ashdod Rail. The offering package also attached a December 31, 2025 valuation that put BIG Fashion Ashdod at NIS 1.31 billion on a 100% basis.
So what opened in February was not a general-purpose cash faucet. It was the ability to package a specific asset for the secured debt market, increase the rated size between late January and early February, and push part of the pressure out to 2032.
What It Covered, And What It Did Not
To read the raise correctly, the starting point is Note 1. As of December 31, 2025 BIG had a consolidated working-capital deficit of NIS 3.116 billion and a standalone deficit of NIS 1.423 billion. That note traces the pressure at the parent level mainly to three identified items: roughly NIS 540 million of Series H due in April 2026, about NIS 405 million of commercial paper, and about NIS 200 million of Series I due in December 2026.
Those three layers alone add up to about NIS 1.145 billion. So a NIS 1 billion issue is large, but it does not eliminate the parent's identified near-term funding stack, and certainly not the entire standalone working-capital deficit.
That is before the proceeds are even allocated. The prospectus states explicitly that the issue proceeds will be used, among other things, to repay the remaining Series H balance, including interest and indexation, and in addition to finance ongoing activity, investments in Israel and abroad, and the refinancing of existing financial debt. In other words, the document itself does not frame Series 25 as clean excess cash waiting for optional growth. It is refinancing money plus operating flexibility, not a new war chest.
The most important sentence on this point sits in Note 16. After the reporting date, the company states that it issued Series 25 and pledged BIG Fashion Ashdod instead of the pledge previously recorded in favor of Series H. That is the core of the story. The new series did not free Ashdod. It moved the same collateral engine from an older secured series nearing maturity into a new and longer-dated one.
That is why reading February 2026 as if BIG suddenly gained NIS 1 billion of brand-new headroom is too generous. Much of what opened was an extension of life for an existing secured layer, not the creation of new unencumbered liquidity.
Covenants: The Cushion Exists, But It Is Not The Bottleneck
This is where the common confusion begins. If one looks only at the covenants, the picture is very comfortable.
| Layer | Threshold in the Series 25 documents | Actual position at year-end 2025 | What it means |
|---|---|---|---|
| Minimum adjusted equity | NIS 6.5 billion in the final prospectus | Reported total equity was NIS 15.7 billion | Even before any adjustment, the cushion was about NIS 9.2 billion |
| Adjusted equity to balance-sheet ratio | At least 20% | Reported total equity was about 35.0% of the balance sheet | There is no technical covenant proximity here |
| Collateral framework | Rating capped at 80% loan-to-value in the rating notices | Depends on a specific Ashdod collateral package | Issue capacity is driven by asset packaging, not only by the consolidated balance sheet |
There is one more useful nuance here. In the draft deed of trust attached to the January 26 notice, the minimum adjusted equity threshold still stood at NIS 6.0 billion. In the final prospectus it was raised to NIS 6.5 billion. So the final documents modestly tightened the equity floor, yet even after that tightening the cushion remained very wide.
That means the real question is not whether BIG is close to tripping a covenant. It is not. The real question is how much practical financing can still be extracted from the asset base and from the market without steadily loading more collateral onto the structure, and without turning every bit of room into a refinancing exercise.
Where The Real Financing Headroom Sits
The same Note 1 provides the fuller map of the resources available to the company outside AFI:
- In February 2026 the company raised NIS 1 billion in Series 25.
- A financial institution extended a roughly NIS 600 million credit line until June 2026 against a lien on part of the AFI shareholding, and the company states that this line was fully available as of the reporting date and the financial statement publication date.
- Excluding AFI, the company had about NIS 5.693 billion of available unpledged properties, of which about NIS 5.416 billion were yielding properties.
- The company held about 23.9 million marketable AFI shares valued at about NIS 5.588 billion and estimated that financing could also be raised against them.
This chart shows why the answer to the headroom question is both "a lot" and "less than it looks". On one hand, BIG clearly has deep collateral reservoirs. On the other hand, only the NIS 600 million facility is an immediate signed line. The unpledged properties and the AFI share value are potential funding pools that still need to be activated through new pledges, refinancings, or monetization. They are not cash already sitting freely at the parent.
This is where Midroog adds the most disciplined read. The rating report describes the company's liquidity as good and based on stable operating cash flow, meaningful cash balances, unused signed credit lines, and a relatively comfortable maturity schedule. But the same report also says that AFI is treated as an equity holding for leverage, coverage, and liquidity because there is no financing linkage between the companies and BIG does not rely on AFI cash flows. Midroog's base case also does not assume dividends from AFI.
That is the clean difference between paper value and practical financing room. AFI is clearly a source of financing optionality. It is not the same thing as a standing upstream cash pipe into the parent.
The same logic applies to commercial paper. Midroog states that the CP rating is based not only on the issuer rating but also on the company's 12-month sources-and-uses profile and on the company's statement that it will maintain signed unused credit lines or cash balances no lower than the outstanding CP balance, in order to meet an immediate repayment demand within 14 business days. In other words, part of BIG's liquidity is functionally pre-reserved for CP discipline, even if it is not legally encumbered in the same way as a real-estate asset.
Conclusion
The February 2026 raise did open real financing room for BIG. It proved market access, extended duration, increased the issue from a NIS 750 million initial rating scope to NIS 1 billion, and gave the parent an effective refinancing tool against 2026 maturities. That is not a trivial outcome.
But it is also not a clean reset of the funding question. The covenants look comfortable, so they are not the center of the debate. The center of the debate is something else: how much of BIG's room still depends on unpledged assets, how much depends on the ability to keep refinancing against properties and AFI shares, and how much liquidity needs to remain reserved so that commercial paper stays a usable tool.
So the right read after February 2026 is this: real financing headroom opened, but it is execution headroom and refinancing headroom, not full freedom. For that room to feel truly wide, BIG will need to move through 2026 without turning more and more layers of specific collateral into a permanent answer for recurring funding needs.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.